{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:48:33Z","timestamp":1783086513249,"version":"3.54.6"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.psychres.2020.113017","type":"journal-article","created":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T01:55:00Z","timestamp":1589680500000},"page":"113017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder"],"prefix":"10.1016","volume":"290","author":[{"given":"Richard C.","family":"Shelton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar V.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Rothschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Thase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boadie W.","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"DeBattista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent P.","family":"Forester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Macaluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aime Lopez","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Jablonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Greden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.psychres.2020.113017_bib0001","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/tpj.2014.85","article-title":"Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes","volume":"15","author":"Altar","year":"2015","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"10.1016\/j.psychres.2020.113017_bib0002","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41397-018-0027-3","article-title":"Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools","volume":"18","author":"Bousman","year":"2018","journal-title":"Pharmacogenomics Journal"},{"issue":"2","key":"10.1016\/j.psychres.2020.113017_bib0003","article-title":"A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders","volume":"17","author":"Brennan","year":"2015","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.psychres.2020.113017_bib0004","article-title":"Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group","author":"Caudle","year":"2019","journal-title":"Clinical and Translational Science."},{"issue":"10","key":"10.1016\/j.psychres.2020.113017_bib0005","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1177\/1060028013501994","article-title":"A comparison of the risk of QT prolongation among SSRIs","volume":"47","author":"Funk","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.psychres.2020.113017_bib0006","series-title":"(Revised 2015, Reafirmed 2015). Practice guideline for the treatment of patients with major depressive disorder","author":"Gelenberg","year":"1993"},{"key":"10.1016\/j.psychres.2020.113017_bib0007","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpsychires.2019.01.003","article-title":"Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study","volume":"111","author":"Greden","year":"2019","journal-title":"J Psychiatr Res"},{"issue":"10","key":"10.1016\/j.psychres.2020.113017_bib0008","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/FPC.0b013e3283649b9a","article-title":"Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting","volume":"23","author":"Hall-Flavin","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.psychres.2020.113017_bib0009","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1038\/tp.2012.99","article-title":"Using a pharmacogenomic algorithm to guide the treatment of depression","volume":"2","author":"Hall-Flavin","year":"2012","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2020.113017_bib0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cpt.147","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors","volume":"98","author":"Hicks","year":"2015","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.psychres.2020.113017_bib0011","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2217\/pme-2017-0094","article-title":"Analytical validation of a psychiatric pharmacogenomic test","volume":"15","author":"Jablonski","year":"2018","journal-title":"Personalized Medicine"},{"issue":"4","key":"10.1016\/j.psychres.2020.113017_bib0012","first-page":"263","article-title":"Basic review of the cytochrome p450 system","volume":"4","author":"McDonnell","year":"2013","journal-title":"Journal of the advanced practitioner in oncology"},{"issue":"7","key":"10.1016\/j.psychres.2020.113017_bib0013","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.mayocp.2016.02.023","article-title":"Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine","volume":"91","author":"Nassan","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.psychres.2020.113017_bib0014","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12888-017-1412-1","article-title":"Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial","volume":"17","author":"P\u00e9rez","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2020.113017_bib0015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.clpt.6100291","article-title":"Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients","volume":"83","author":"Rudberg","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.psychres.2020.113017_bib0016","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2020.113017_bib0017","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/FPC.0b013e328346063f","article-title":"PharmGKB summary: citalopram pharmacokinetics pathway","volume":"21","author":"Sangkuhl","year":"2011","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"10.1016\/j.psychres.2020.113017_bib0018","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/FPC.0b013e32834d4962","article-title":"PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19","volume":"22","author":"Scott","year":"2012","journal-title":"Pharmacogenet Genomics"},{"issue":"8","key":"10.1016\/j.psychres.2020.113017_bib0019","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4088\/JCP.v66n0803","article-title":"Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials","volume":"66","author":"Thase","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psychres.2020.113017_bib0020","unstructured":"U.S. Food & Drug Administration, 2019. Celexa: Labeling-Container\/Carton Labels."},{"key":"10.1016\/j.psychres.2020.113017_bib0021","unstructured":"U.S. Food and Drug Administration, 2017. Celexa: Labeling-Package Insert."},{"issue":"4","key":"10.1016\/j.psychres.2020.113017_bib0022","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/clpt.2012.96","article-title":"Pharmacogenomics knowledge for personalized medicine","volume":"92","author":"Whirl-Carrillo","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.psychres.2020.113017_bib0023","first-page":"219","article-title":"A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder","volume":"16","author":"Winner","year":"2013","journal-title":"Discov Med"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811932462X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811932462X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:40:55Z","timestamp":1759038055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517811932462X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":23,"alternative-id":["S016517811932462X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113017","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113017"}}